Hunting for the first signs of cancer spread in the blood

NCT ID NCT04424719

Recruiting now Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

Summary

This study aims to find blood markers that can detect the early spread of uveal melanoma (a type of eye cancer) to the liver. It will follow 700 patients at high risk of relapse, giving them regular MRI scans and blood tests for up to 10 years. The goal is to learn if these markers can help create more personalized check-up schedules to catch cancer spread sooner.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Institut Curie
RECRUITING

Paris, 75005, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

UVEAL MELANOMA